Drawing for STANDARD GLUCO NAVII

USPTO serial 97630309

STANDARD GLUCO NAVII

Reviewed by CopyMark Law Group

Reg. 7787782Status 700Registered
Filing date
Status date
Registration date
May 6, 2025
Examiner
BROWN, TINA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with STANDARD GLUCO NAVII?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian P. Gregg

Brian P. Gregg MCNEES WALLACE & NURICK100 PINE STREETHARRISBURG, PA 17108United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic preparations for medical use for diagnosing tuberculosis; diagnostic chemical preparations for medical use for the diagnosis of diabetes; diagnostic reagents for immunization disease for medical or veterinary use; medical diagnostic agents for pharmaceutical use; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; diagnostic preparations for medical and veterinary use; medical diagnostic test strips for testing and analysis of body fluids; medical diagnostic reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents; diagnostic preparations for medical purposes; diagnostic chemical reagents for medical use; in vitro diagnostic preparations for medical purposes; medical diagnostic reactants for medical diagnosis; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis, namely, pharmaceutical diagnostic preparations for medical purposesACTIVE
010Indicators for medical diagnosis, namely, glucose meters; diagnostic medical apparatus for automatic diagnosis of tuberculosis; diagnostic measuring apparatus for medical use for the analysis of body fluids; diagnostic testing instruments for use in medical immunoassay procedure, namely, medical diagnostic apparatus for measuring blood glucose levels; apparatus for carrying-out diagnostic tests for medical purposes, namely, medical diagnostic apparatus for measuring blood glucose levels; diagnostic apparatus for medical purposes, namely, medical diagnostic apparatus for measuring blood glucose levels; medical apparatus and instruments in the fields of clinical diagnosis, namely, medical diagnostic apparatus for measuring blood glucose levels; diagnostic, examination, and monitoring equipment, namely, medical diagnostic apparatus for the measurement of blood glucose levels, patient monitoring sensors; testing instruments for medical diagnostic purposes, namely, blood testing apparatus; tools for medical diagnostics, namely, probes for medical purposes; sensor apparatus for medical use in diagnosis, namely, medical products in the nature of biofeedback sensors, electrochemical sensors for determination of analyte concentrations in fluids for medical purposes; testing probes for medical diagnostic purposes; medical diagnostic apparatus for medical purposes, namely, medical diagnostic apparatus for measuring blood glucose levels; in vitro diagnostic devices for medical purposes, namely, in vitro medical diagnostic apparatus for measuring blood glucose levelsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 6, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
May 6, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 11, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 11, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 8, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2025ALIEASSIGNED TO LIE
Mar 26, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 28, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2025CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE
Feb 13, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 13, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 3, 2024IUAFUSE AMENDMENT FILED
Dec 3, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 27, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 26, 2024EX1GSOU EXTENSION 1 GRANTED
Apr 26, 2024EXT1SOU EXTENSION 1 FILED
Apr 26, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 12, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 17, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 27, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 11, 2023XAECEXAMINER'S AMENDMENT ENTERED
Sep 11, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 11, 2023GNEAEXAMINERS AMENDMENT E-MAILED
Sep 11, 2023CNEAEXAMINERS AMENDMENT -WRITTEN
Sep 7, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Sep 7, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 7, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 6, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 6, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 22, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 22, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 20, 2023DOCKASSIGNED TO EXAMINER
Oct 27, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 17, 2022NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance